Creation of a Shared Medical Decision-making Tool for Atopic Dermatitis
NCT05090982 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2021-12-21
Summary
Hypothesis/Objective : Patient-centered health care and shared decision making are key components of increasing importance which are recommended by the French Haute Autorite de Sante (HAS) and World Health Organization (WHO).
In the context of dermatology and atopic dermatitis, European guidelines has promoted an active involvement from both patients and caregivers in therapeutic decisions at all stages to achieve therapeutic success and the Task Force on Atopic Dermatitis (ETFAD) has promoted the setting of treatment goals in a shared decision with the patient.
The main objective of this study is to develop and cross culturally validate a tool dedicated to shared-decision in atopic dermatitis that can be used during routine dermatological consultations.
The second objective is to better characterize patients seen in this context and to evaluate patients' satisfaction when empowered by shared decision.
Method : We aim to develop a SDMt in AD following the recommendations of the International Patient Decision Aid Standards (IPDAS) collaboration. Development will use a multistep approach: 1) identification of priority domains for patients; 2) Selection of domains to be included in the SDMt for AD; and 3) Creation and testing of the SDMt.
Participants will be consecutive adult (\>18 years old) patients attending consultation for a AD in medical centres in France (Toulouse, Nantes and Créteil). All participants will provide written consent to participate. The study will be submitted for approbation to the local ethics committees of the University Hospital Centres of Paris and will be conducted according to the Declaration of Helsinki.
Step 1: Identification of priority domains for patients
Step 2: Selection of domains to be included in the SDMt for AD
Step 3: Creation and testing of the SDMt
Conditions
Interventions
- OTHER
-
Audio recordings during the consultations
50 patients with audio recordings of the consultation
- OTHER
-
Audio recordings during the consultations and test of the shared medical decision-making tool for modification
50 patients with audio recording of the consultation and Test of the shared medical decision-making tool for modification
- OTHER
-
Audio recordings during the consultations and test of the shared medical decision-making tool for validation
50 patients with audio recording of the consultation and test of the shared medical decision-making tool for validation.
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Pierre-André Natella, PhD · Assistance Publique - Hôpitaux Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-31
- Primary Completion
- 2022-11-30
- Completion
- 2022-11-30
Countries
- France
Study Locations
More Related Trials
-
A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families
NCT02067234 ·Status: WITHDRAWN ·Phase: NA
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
NCT04504955 ·Status: ENROLLING_BY_INVITATION
-
Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD
NCT05639738 ·Status: TERMINATED ·Phase: NA
-
Text Messaging and Atopic Dermatitis
NCT01216059 ·Status: COMPLETED ·Phase: NA
-
Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
NCT06174493 ·Status: NOT_YET_RECRUITING
-
Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy
NCT03090178 ·Status: COMPLETED ·Phase: NA
-
Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent Handbook
NCT03722706 ·Status: COMPLETED ·Phase: NA
-
Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients
NCT06983561 ·Status: COMPLETED
-
Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis
NCT00690833 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis
NCT03492398 ·Status: COMPLETED ·Phase: PHASE1
-
Microbiome in Atopic Dermatitis Under Systemic Therapy
NCT05099315 ·Status: RECRUITING
-
A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
NCT02634905 ·Status: TERMINATED ·Phase: NA
-
Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic Dermatitis
NCT07017348 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes
NCT07009483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
NCT05990725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
China Atopic Dermatitis Registry Study
NCT05023668 ·Status: UNKNOWN
-
Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis
NCT05833880 ·Status: COMPLETED
-
The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis
NCT02343861 ·Status: COMPLETED ·Phase: NA
-
Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management
NCT01660217 ·Status: COMPLETED ·Phase: NA
-
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT05999799 ·Status: TERMINATED ·Phase: PHASE2
-
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
NCT05916365 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
NCT06815380 ·Status: RECRUITING
-
A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries
NCT05214326 ·Status: COMPLETED
-
Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis
NCT04761978 ·Status: WITHDRAWN